HTG Molecular Diagnostics, Inc.
NASDAQ: HTGM0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- John L. Lubniewski
- Employees
- 53
- Headquarters
- Tucson, United States
- IPO year
- 2015
- Market cap
- $1.1M
- Website
- https://www.htgmolecular.com
Loading HTGM…
Loading profile data…Frequently asked questions about HTGM
What does HTG Molecular Diagnostics, Inc. (HTGM) do?
Based in Tucson, Arizona, HTG Molecular Diagnostics, Inc. is a life sciences company dedicated to advancing precision medicine. They provide a comprehensive suite of products, including specialized instruments, assay kit consumables, and software solutions, all designed to automate sample processing and accurately profile various molecular targe...
Where does HTGM trade?
HTG Molecular Diagnostics, Inc. (HTGM) trades on the NASDAQ Capital Market.
What sector is HTGM in?
HTG Molecular Diagnostics, Inc. (HTGM) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of HTG Molecular Diagnostics, Inc.?
John L. Lubniewski is the chief executive officer of HTG Molecular Diagnostics, Inc. (HTGM).
Where is HTG Molecular Diagnostics, Inc. headquartered?
HTG Molecular Diagnostics, Inc. is headquartered in United States.
Does HTGM pay a dividend?
HTG Molecular Diagnostics, Inc. (HTGM) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HTGM go public?
HTG Molecular Diagnostics, Inc. (HTGM) completed its initial public offering in 2015.